Peptide Education
Peptide Purity vs Identity vs Content: What Each Laboratory Result Means
31
Aug
Aug
- WE SHIP WITHIN 24 HOURS USPS PRIORITY MAIL 3-5 DAYS
- WE SHIP WITHIN 24 HOURS USPS PRIORITY MAIL 3-5 DAYS
“What is the purity?” is one of the most common questions asked before purchasing a research peptide. It is also incomplete. Purity, identity and peptide content describe different characteristics, and substituting one for another can create errors in procurement and experimental planning.
Identity testing seeks evidence that the material corresponds to the expected peptide. Mass spectrometry is commonly used because the observed molecular mass can be compared with a theoretical value. Depending on the analytical objective, additional characterization may be appropriate.
An identity result does not by itself quantify every impurity or establish the total amount of peptide present.
Reverse-phase HPLC can separate a peptide from detectable related components under defined conditions. The main-peak area may be reported as a percentage of the total integrated area.
This is valuable information, but it remains method-dependent. Detector response, sample preparation, wavelength, gradient and integration choices influence the result. A high main-peak percentage is not a universal measurement of everything inside a lyophilized vial.
Peptide content or assay aims to quantify the amount of peptide relative to the sample or stated quantity. Water, salts and counter-ions can contribute mass without being the target peptide. A content result therefore answers a question that a simple chromatographic area percentage may not.
Imagine a document that reports a strong identity match and a high HPLC main-peak percentage. Those results support two conclusions: the expected molecule was detected, and the principal detected peptide-related component dominated the chromatogram. They do not automatically establish sterility, endotoxin level, vial fill uniformity or exact net peptide content.
The appropriate analytical package depends on the laboratory application. A qualitative pathway study, a quantitative reference standard and a regulated analytical workflow may require very different evidence.
Terms such as “research grade,” “pharmaceutical grade” or “clinical grade” can be ambiguous unless a supplier defines the applicable specifications and quality system. Specific test methods and results are more informative than an unexplained marketing label.
No. Different methods answer different analytical questions.
Not in isolation. Method quality, identity evidence, batch traceability and suitability for the intended protocol also matter.
Use the research peptide supplier checklist and review product-specific documentation before ordering from the GenLab Meds catalog.
Sources: Synthetic peptide reference-standard characterization; LC-HRMS for peptide quality control
